The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-4-(4-Nonylphenyl)-4-oxobut-2-enoic Acid ID: ALA5181434
PubChem CID: 168272357
Max Phase: Preclinical
Molecular Formula: C19H26O3
Molecular Weight: 302.41
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCc1ccc(C(=O)/C=C/C(=O)O)cc1
Standard InChI: InChI=1S/C19H26O3/c1-2-3-4-5-6-7-8-9-16-10-12-17(13-11-16)18(20)14-15-19(21)22/h10-15H,2-9H2,1H3,(H,21,22)/b15-14+
Standard InChI Key: IYOLTUMKGMSVMI-CCEZHUSRSA-N
Molfile:
RDKit 2D
22 22 0 0 0 0 0 0 0 0999 V2000
-0.7131 2.4770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0013 2.8893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7132 2.4774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7132 1.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0031 1.2404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7131 1.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4279 2.8900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4279 3.7152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1425 2.4774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8571 2.8900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5718 2.4774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2864 2.8900 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5718 1.6522 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4278 1.2359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4278 0.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1425 -0.0018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1425 -0.8270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8570 -1.2396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8570 -2.0648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5717 -2.4774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5717 -3.3025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2864 -3.7152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
7 8 2 0
7 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
11 13 2 0
6 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 302.41Molecular Weight (Monoisotopic): 302.1882AlogP: 4.80#Rotatable Bonds: 11Polar Surface Area: 54.37Molecular Species: ACIDHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.26CX Basic pKa: ┄CX LogP: 5.78CX LogD: 2.35Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.36Np Likeness Score: 0.28
References 1. Kudo Y, Endo S, Fujita M, Ota A, Kamatari YO, Tanaka Y, Ishikawa T, Ikeda H, Okada T, Toyooka N, Fujimoto N, Matsunaga T, Ikari A.. (2022) Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer., 65 (6.0): [PMID:35244402 ] [10.1021/acs.jmedchem.1c02113 ]